Welcome to our virtual exhibit booth!

About Us

BeiGene is a global, commercial-stage biotechnology company focused on discovering, developing, manufacturing, and commercializing innovative medicines to improve treatment outcomes and access for patients worldwide.

Our 4,000+ employees in China, the United States, Australia, and Europe are committed to expediting the development of a diverse pipeline of novel therapeutics for cancer. We currently market an internally-discovered product, BRUKINSA® (zanubrutinib) in the United States.

Twitter  LinkedIn



Click the graphics below to open the links or download.

BeiGene: Blood Cancer Has No Borders, Neither Do We

Prescribing Information

Dosing & Administration

Patient Support

Learn More About BeiGene

Contact Us